World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
40
Citations
8251
World Ranking
4924
National Ranking
413

Georgios Pollakis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Georgios Pollakis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 138 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Georgios Pollakis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Georgios Pollakis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 40 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Georgios Pollakis is affiliated with the University of Liverpool in the United Kingdom. Their research focuses primarily on the field of medicine, with specific attention to infectious diseases, virology, neurology, epidemiology, and pulmonary and respiratory medicine.

The main topics covered in their work include SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, HIV research and treatment, long-term effects of COVID-19, HIV/AIDS drug development and treatment, HIV/AIDS research and interventions, and viral infections and outbreaks research.

Frequent coauthors collaborating with Georgios Pollakis include:

  • Malcolm G. Semple
  • J. Kenneth Baillie
  • Peter Openshaw
  • William A. Paxton
  • Annemarie B Docherty

Frequent publication venues where Georgios Pollakis has contributed include:

  • Frontiers in Immunology
  • Scientific Reports
  • The Lancet Respiratory Medicine
  • Nature Communications
  • Genome Biology

Recent published papers by Georgios Pollakis are:

  • Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study, 2021, The Lancet Microbe
  • Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19, 2021, Science Immunology
  • Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study, 2020, American Journal of Respiratory and Critical Care Medicine
  • Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study, 2021, The Lancet Respiratory Medicine
  • Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK, 2021, The Lancet Respiratory Medicine

Best Publications

  • Real-time, portable genome sequencing for Ebola surveillance

    Joshua Quick;Nicholas J. Loman;Sophie Duraffour;Jared T. Simpson;Jared T. Simpson

  • Genetic mechanisms of critical illness in Covid-19.

    E. Pairo-Castineira;E. Pairo-Castineira;S. Clohisey;L. Klaric;A. D. Bretherick

  • PD-1 + and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals

    Riddhima Banga;Francesco Andrea Procopio;Alessandra Noto;Georgios Pollakis

  • Virus genomes reveal factors that spread and sustained the Ebola epidemic

    Gytis Dudas;Gytis Dudas;Luiz Max Carvalho;Trevor Bedford;Andrew J. Tatem

  • Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa

    Miles W. Carroll;David A. Matthews;Julian A. Hiscox;Michael J. Elmore

  • N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization

    Georgios Pollakis;Stanley Kang;Aletta Kliphuis;Moustapha I.M. Chalaby

  • Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

    Clark D Russell;Cameron J Fairfield;Thomas M Drake;Lance Turtle

  • Preferential infection and depletion of Mycobacterium tuberculosis–specific CD4 T cells after HIV-1 infection

    Christof Geldmacher;Njabulo Ngwenyama;Alexandra Schuetz;Constantinos Petrovas

  • Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.

    Ryan S Thwaites;Ashley Sanchez Sevilla Uruchurtu;Matthew K Siggins;Felicity Liew

  • Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4(+) T lymphocytes

    Marloes A. Naarding;Irene S. Ludwig;Fedde Groot;Ben Berkhout

  • HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with Aids

    A Abebe;D Demissie;J Goudsmit;M Brouwer

  • Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.

    Chloe I Bloom;Thomas M Drake;Annemarie B Docherty;Brian J Lipworth

  • Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition by CC/CXC Chemokines, Soluble CD4, and the b12 and 2G12 Monoclonal Antibodies

    Alexey A. Nabatov;Georgios Pollakis;Thomas Linnemann;Aletta Kliphius

  • Mitochondrial development in Trypanosoma brucei brucei transitional bloodstream forms

    E. J. Bienen;Muhamed Saric;G. Pollakis;R. W. Grady

  • Apelin, the Natural Ligand of the Orphan Seven-Transmembrane Receptor APJ, Inhibits Human Immunodeficiency Virus Type 1 Entry

    Mark Cayabyab;Shuji Hinuma;Michael Farzan;Hyeryun Choe

  • Human Immunodeficiency Virus Type 1 Subtypes Have a Distinct Long Terminal Repeat That Determines the Replication Rate in a Host-Cell-Specific Manner

    Tim van Opijnen;Rienk E. Jeeninga;Maarten C. Boerlijst;Georgios P. Pollakis

  • SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

    Unknown

  • Efficient Capture of Antibody Neutralized HIV-1 by Cells Expressing DC-SIGN and Transfer to CD4+ T Lymphocytes

    Thijs van Montfort;Alexey A. Nabatov;Alexey A. Nabatov;Teunis B. H. Geijtenbeek;Georgios Pollakis

  • Phenotypic and Genotypic Comparisons of CCR5- and CXCR4-Tropic Human Immunodeficiency Virus Type 1 Biological Clones Isolated from Subtype C-Infected Individuals

    Georgios Pollakis;Almaz Abebe;Aletta Kliphuis;Moustapha I. M. Chalaby

  • Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells

    Marloes A. Naarding;Annette M. Dirac;Irene S. Ludwig;Dave Speijer

  • Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes.

    Marloes A Naarding;Elly Baan;Georgios Pollakis;William A Paxton

  • Optimization of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins with V1/V2 Deleted, Using Virus Evolution

    Ilja Bontjer;Aafke Land;Dirk Eggink;Erwin Verkade

  • Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study.

    Thomas M Drake;Cameron J Fairfield;Riinu Pius;Stephen R Knight

Frequent Co-Authors

William A. Paxton
William A. Paxton University of Liverpool
Jaap Goudsmit
Jaap Goudsmit Harvard University
Ben Berkhout
Ben Berkhout University of Amsterdam
Julian A. Hiscox
Julian A. Hiscox University of Liverpool
Rogier W. Sanders
Rogier W. Sanders University of Amsterdam
Samreen Ijaz
Samreen Ijaz Public Health England
Andrew Rambaut
Andrew Rambaut University of Edinburgh
Suzanne Jurriaans
Suzanne Jurriaans University of Amsterdam
Debby Bogaert
Debby Bogaert University of Edinburgh
Peter J. M. Openshaw
Peter J. M. Openshaw Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with healthcare professions such as nursing and nurse practitioner roles. For those interested in advancing their nursing career alongside immunology studies, exploring affordable pmhnp programs can provide a cost-effective way to specialize in psychiatric and mental health nursing online.

Understanding potential earnings is also crucial when considering advanced degrees. The comprehensive data on how much do dnp nurses make offers valuable insights into salary expectations, helping students plan their educational investments wisely.

Career transitions are common in nursing as professionals seek new challenges. Nurses aiming to shift their focus toward intensive patient care can benefit from programs detailing the acute care np certification, facilitating a smooth transition into specialized acute care roles.

For motivated students looking to expedite their journey, accelerated np programs online offer accelerated pathways to becoming nurse practitioners, allowing them to enter their careers faster without compromising educational quality.

Best Scientists Citing Georgios Pollakis

Trending Scientists

Recently Published Articles